Veerhealth Care Ltd. has announced securing its largest order worth ₹5.49 crores from one of India's leading Fast Moving Consumer Goods (FMCG) companies for personal care products. The order, valued at approximately ₹5.50 crores excluding GST, represents a substantial milestone for the company and provides significant revenue visibility for the current financial year.

Order Significance and Financial Impact

The contract demonstrates remarkable scale relative to the company's current operations. With Q3 FY26 revenue from operations at ₹7.26 crores, this single order represents approximately 76% of the quarterly revenue. More significantly, the order alone constitutes about 20% of the company's expected revenues for FY 2025-26.

Order Details and Client Profile

The contract involves supplying face care products to a prominent domestic FMCG company that operates in both domestic and international markets within the personal and household care segment. The client is part of a 125-year-old established business group, adding credibility to the partnership. While the client's identity remains confidential due to contractual terms, the order must be executed within a tight 45-day timeline.

Future Revenue Projections and Growth Strategy

Management has provided ambitious growth projections for the coming years. For FY 2026-27, the company expects total revenues of ₹45-50 crores with a profit after tax (PAT) margin of 7-10%. However, considering ongoing discussions for orders from both domestic and export buyers, the company anticipates potentially exceeding these revenue targets.

Competitive Positioning and Manufacturing Capabilities

Veerhealth Care has established a distinctive market position through its USFDA plant clearance, a certification achieved by very few small-cap companies globally. The company specializes in manufacturing pure vegetarian toothpaste and operates under the Ayuveer brand, which focuses on crafting ayurvedic medicines and oral care products using natural ingredients. This combination of regulatory approval and specialized manufacturing capabilities positions the company favorably for future growth in the personal care segment.

Regulatory Compliance and Corporate Governance

The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has confirmed that no promoter, promoter group, or group companies have any interest in the entity that awarded the order, ensuring the transaction maintains high corporate governance standards and does not constitute a related party transaction.

VeerHealth Care Limited has released a comprehensive investor presentation under Regulation 30, showcasing its US FDA certification achievement and strategic expansion plans. The company secured US FDA certification for Drug (OTC) products following a successful audit that concluded in June 2025, positioning itself among the few small-cap companies globally with FDA-cleared manufacturing facilities.

Company Background and Strategic Evolution

VeerHealth Care was originally incorporated on July 10, 1992, as Niyati Leasing Limited, focusing on investment and finance activities. The company underwent strategic transformation in 2013 when management decided to diversify into the pharmaceutical sector, subsequently changing its name to VeerHealth Care Limited. In 2020, the company expanded into cosmetic manufacturing and specializes in producing pure vegetarian toothpaste.

Manufacturing Infrastructure and Capacity

The company operates from a state-of-the-art manufacturing facility spanning 90,000 sq. ft. in Vapi, equipped with comprehensive production and packaging capabilities. The facility includes specialized equipment for various product categories.

Financial Performance and Projections

The company has demonstrated consistent growth trajectory with strong financial fundamentals. The latest financial results show improved operational performance.

Expansion Plans and Funding Strategy

VeerHealth Care has announced an ambitious ₹33 crore expansion project to enhance healthcare solutions, covering land acquisition, building construction, procurement of machinery, and infrastructure development. The company will fund this expansion through a rights issue.

Global Market Presence and Strategic Partnerships

The company has established a significant international footprint, exporting products to multiple countries across different continents through both direct and merchant exporter channels.

Export Markets Include:

• Africa: Kenya, Uganda, Tanzania, Burundi, Rwanda, Morocco, Angola, Sudan, Somalia, Sierra Leone, Liberia
• Middle East: UAE, Yemen
• Asia: Hong Kong
• Americas: Haiti, Utah, North Carolina
• Europe: UK

The company has recently onboarded a leading FMCG company that operates in domestic and international markets within the personal and household care segment. This company is part of a 125-year-old prominent business group, representing a significant strategic partnership for VeerHealth Care.

Backward Integration and Product Innovation

VeerHealth Care has launched VeerPlast as a backward integration initiative in 2025, manufacturing packaging and components for its oral and personal care product lines. This division includes blow molding and injection molding capabilities, along with brush tufting and trimming lines to support export operations.

The company has successfully pioneered in manufacturing Clear Gel Toothpaste and exported the same to one of the top institutional supplier companies in the United States under Private Label. The company's Ayuveer brand has successfully completed onboarding on Myntra and is available on various e-commerce platforms including Amazon, Nykaa, and Flipkart.

Financial Strength and Asset Base

The company maintains a low-debt structure with borrowings of only ₹5-7 crore and substantial asset base including land assets valued at approximately ₹20 crore and total assets including machinery worth approximately ₹35 crore. The US FDA certification enables VeerHealth Care to export Drug (OTC) products to the USA and unlock access to other international markets, aligning with its "Local to Global" vision.